Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The immunology of renal cell carcinoma
Renal cell carcinoma (RCC) is the most common type of kidney cancer and comprises
several subtypes with unique characteristics. The most common subtype (~ 70% of cases) is …
several subtypes with unique characteristics. The most common subtype (~ 70% of cases) is …
Resistance to systemic therapies in clear cell renal cell carcinoma: mechanisms and management strategies
Renal cell carcinoma (RCC) is the most common form of kidney cancer. It is categorized into
various subtypes, with clear cell RCC (ccRCC) representing about 85% of all RCC tumors …
various subtypes, with clear cell RCC (ccRCC) representing about 85% of all RCC tumors …
[HTML][HTML] Exosomes in the diagnosis and treatment of renal cell cancer
Renal cell carcinoma (RCC) is the most prevalent type of kidney cancer originating from
renal tubular epithelial cells, with clear cell RCC comprising approximately 80% of cases …
renal tubular epithelial cells, with clear cell RCC comprising approximately 80% of cases …
N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell …
Y Chen, Z Lu, C Qi, C Yu, Y Li, W Huan, R Wang… - Molecular cancer, 2022 - Springer
Background Sunitinib resistance can be classified into primary and secondary resistance.
While accumulating research has indicated several underlying factors contributing to …
While accumulating research has indicated several underlying factors contributing to …
TFEB mediates immune evasion and resistance to mTOR inhibition of renal cell carcinoma via induction of PD-L1
Purpose: Despite the FDA approval of mTOR inhibitors (mTORi) for the treatment of renal
cell carcinoma (RCC), the benefits are relatively modest and the few responders usually …
cell carcinoma (RCC), the benefits are relatively modest and the few responders usually …